Evidence map›Paper›PMID 41491727›Full record

ReviewNature reviews. Endocrinology2026

Models of hyperglycaemia in diabetes mellitus and its complications.

Ryan Yi Hang Loo, Xinyi Zhang, Carmen Ching, Adrian Kee Keong Teo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ryan Yi Hang LooStem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Xinyi ZhangStem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.ORCID http://orcid.org/0000-0003-0762-1814
Carmen ChingStem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Adrian Kee Keong TeoStem Cells and Diabetes Laboratory, Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore. Adrian_Teo@a-star.edu.sg.ORCID http://orcid.org/0000-0001-5901-7075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is a metabolic disease marked by chronic high blood levels of glucose (also known as hyperglycaemia), which over time can cause damage to the blood vasculature, leading to devastating complications. The increase in global prevalence and the number of cases of type 2 diabetes mellitus continues unabated, prompting diabetes mellitus researchers to continue studying the aetiology of the disease in search of ways to improve therapeutic outcomes. Over the years, numerous in vivo and in vitro mammalian models have been developed to investigate the mechanisms underlying diabetes mellitus and its complications. The customary use or induction of high levels of glucose in vivo or in vitro to recapitulate chronic hyperglycaemia in diabetes mellitus is central to these models. However, there has never been a consensus as to how to standardize the re-creation of glucotoxicity conditions so that the pathophysiological effects in human diabetes mellitus can be accurately mimicked experimentally. In this Review, we critically discuss glucotoxicity (without lipotoxicity) in diabetes mellitus and analyse the various in vivo and in vitro models used to study the conditions created by high levels of glucose in diabetes mellitus. Efforts to standardize experimental induction or administration of high levels of glucose, and understanding the pros and cons of each model, could help harmonize findings that will benefit the diabetes mellitus research community.

Indexed as

Diabetes ComplicationsDiabetes Mellitus, Type 2Disease Models, AnimalHyperglycemiaAnimalsBlood GlucoseHumansBlood Glucose

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.